ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Three NCI Basic Science Centers Rank In Index Of Citations; Novello: Help More Smokers Quit

August 2, 1991

NCI to Recompete contracts for Frederick

December 4, 1992

Bladder Cancer “Headquarters” Grant Program Seeks Applications For High Priority Research

March 1, 1974

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

Illinois Cancer Center Closes Following Veto of State Funds; Was First Consortium Center

December 11, 1992